• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Ophthalmic industry veteran Erin Schallhorn Powers joins Holland Foundation for Sight Restoration Board of Directors

News
Article

Powers, whose father, sister, and brother are ophthalmologists, has held senior executive positions in strategic planning, marketing, and commercial and medical affairs at vision-focused companies.

(Image credit: AdobeStock)

(Image credit: AdobeStock)

Erin Schallhorn Powers, an ophthalmic industry veteran with nearly 20 years of experience, has joined the board of directors of the Holland Foundation for Sight Restoration.

According to a news release, during her career, Powers has held senior executive positions in strategic planning, marketing, and commercial and medical affairs at vision-focused companies, including Johnson & Johnson Vision, Zeiss, Alcon, and AMO/VISX.1

"I am immensely honored to join the Holland Foundation for Sight Restoration Board of Directors," said Powers, whose father, sister, and brother are ophthalmologists.

Powers has an MBA from the Tuck School of Business at Dartmouth and the London Business School. She is involved in several ophthalmic organizations. She is the immediate past-president of the Ophthalmic World Leaders organization, serves on the Board of the International Society of Refractive Surgery, is the industry representative on the Oracle Vision Council, co-chair of the Women of Dartmouth Development Committee, and is a member of the Chief network.1

"I've worked in ophthalmology for 20 years. It is in my DNA,” she added in the news release. “The Holland Foundation is such a worthy cause by helping people improve their quality of life by serving this unmet met with tangible results. Eye care has been my life's passion, so this is a wonderful opportunity."

The mission of the Holland Foundation for Sight Restoration is the restoration of the gift of sight to patients based on the work of Edward Holland, MD, an ophthalmologist specializing in the treatment of severe ocular surface disease.2

Holland is known for developing The Cincinnati Protocol, a technique that can restore vision to patients who have lost their sight due to severe eye conditions.

"We are thrilled that Erin is joining the Holland Foundation board. Her involvement will boost our continuing success in restoring the gift of sight to our patients," Holland said in the news release.

Powers also detailed her own connection to the cause. She lost a brother whose corneas were donated for transplantation. According to the news release, she hopes to leverage her industry experience to help the Holland Foundation increase funding, publicity, and awareness.

"I find it very personally rewarding to be part of an organization that is working to make cornea transplants more available," she said in the news release.

Reference:
  1. Ophthalmic Industry Leader Erin Schallhorn Powers Joins Holland Foundation for Sight Restoration Board of Directors. www.newswire.com. Accessed April 16, 2024. https://www.newswire.com/news/ophthalmic-industry-leader-erin-schallhorn-powers-joins-holland-22298368
  2. ‌About Us. Holland Foundation For Sight Restoration. Accessed April 16, 2024. https://www.hollandfoundationforsight.org/about-us/
Related Videos
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.